Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Sep 09, 2020 3:51pm
120 Views
Post# 31528076

RE:RE:RE:riplazym was in fact flawless, results were spectacular

RE:RE:RE:riplazym was in fact flawless, results were spectacularStups, you start of great and then praise them for being on target, with one month to go.  LOL

They, new management, failed on two previous dates.  H2 2019 and H1 2020 were "confirmed" to use your wording and failed to meet those timelines.

They delivered on the third try, not what I call underpromising.  Get real please.


realstocky wrote: agreed dude, thats fair enough. New management is also more conservative... there's a conservative way of saying the same thing, or to project results. Thomvest is more underpromise, overdeliver, they did it on the BLA imo, with nearly 1 month to go on targeted q3 for submission. I say they delivered nicely on this one.


<< Previous
Bullboard Posts
Next >>